[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336653-105":59,"doc-detail-336653-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","endogenous-osteoprotegerin-opg-represses-er-and-promotes-stemness-and-chemoresistance-in-breast-cancer-cells","Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells","","Breast cancer remains difficult to treat because tumor resistance, recurrence, and metastasis occur frequently, and this is linked to a small subpopulation of cells with stemness features. Osteoprotegerin (OPG), a decoy receptor involved in bone homeostasis, is investigated for its role in breast carcinogenesis. OPG expression is shown to modulate epithelial-to-mesenchymal transition, stemness, angiogenesis, and drug response, with proteomic correlations to EMT- and stemness-related proteins, and functional effects dependent on ERα signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/endogenous-osteoprotegerin-opg-represses-er-and-promotes-stemness-and-chemoresistance-in-breast-cancer-cells/336653/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/endogenous-osteoprotegerin-opg-represses-er-and-promotes-stemness-and-chemoresistance-in-breast-cancer-cells/336653.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on osteoprotegerin (OPG)?","Question",{"text":112,"@type":113},"The study examines how endogenous OPG influences breast cancer progression by repressing ERα and promoting stemness-related behaviors and chemoresistance in breast cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does OPG affect stemness and EMT in breast cancer cells?",{"text":117,"@type":113},"Ectopic OPG expression promotes pro-metastatic processes including epithelial-to-mesenchymal transition (EMT) and stemness, while OPG upregulation correlates with proteins involved in these pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"Does OPG change sensitivity to chemotherapy drugs?",{"text":121,"@type":113},"Yes. OPG upregulation enhances resistance of luminal breast cancer cells to cisplatin and docetaxel, whereas OPG downregulation sensitizes triple-negative breast cancer cells to these drugs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336653,1790197549,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/cddiscovery](www.nature.com/cddiscovery)  \nARTICLE OPEN   \nEndogenous osteoprotegerin (OPG) represses ERα and  \npromotes stemness and chemoresistance in breast cancer cells  \nNoura N. Alraouji 1, Dilek Colak1, Falah H. Al-mohanna2, Ayodele A. Alaiya3 and Abdelilah Aboussekhra 1 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Breast cancer (BC) is the most prevalent cancer and the leading cause of death among women worldwide. The osteoprotegerin (OPG) cytokine, a decoy receptor for RANKL and a key player in bone homeostasis, has pro-and anti-carcinogenic effects in various types of cancer, including breast neoplasms. In the present study, we have shown that ectopic expression of OPG in breast epithelial/cancer cells promotes the pro-metastatic processes epithelial-to-mesenchymal transition (EMT), stemness, angiogenesis as well as the activation of breast stromal ﬁbroblasts. Furthermore, proteomics analysis, which allows the identiﬁcation and quantiﬁcation of a plethora of known and unknown proteins, has shown a strong and signiﬁcant correlation between OPG upregulation and the expression of proteins with functions in EMT and stemness. On the other hand, OPG knockdown in triplenegative breast cancer (TNBC) cells inhibited the formation of cancer stem cells. Importantly, while OPG upregulation signiﬁcantly enhanced the resistance of luminal BC cells to cisplatin and docetaxel, OPG downregulation sensitized TNBC cells to these chemotherapeutic drugs. We have also shown that OPG negatively controls estrogen receptor α (ERα), and OPG upregulation correlated well with the expression of genes related to ER-negative claudin low cells. Collectively, these results show that OPG |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| promotes stemness and the consequent chemoresistance of breast cancer cells. |  |  |\n|  | Cell Death Discovery (2024)10:377; [https://doi.org/10.1038/s41420-024-02151-8](https://doi.org/10.1038/s41420-024-02151-8) |  |\n|  |  |  |\n\nBACKGROUND  \nBreast cancer (BC) is the most prevalent form of cancer diagnosed among women worldwide [1] . Despite the development of several treatment modalities and precision therapeutics, tumor resistance, recurrence, and metastasis remain very frequent among high proportion of these patients [2] . Several lines of evidence indicate that the main reason for these anti-cure obstacles is the presence of a small population of cells with stemness features called breast cancer stem cells (BCSCs) . These cells have several characteristics, including self-renewal ability, the capability to differentiate into different lineages, the capacity to evade cell death, and also the ability to metastasize [3, 4] . The presence of a high proportion of BCSCs is associated with disease progression, tumor aggressiveness, and drug resistance in breast cancer [4, 5] . Therefore, there isan urgent demand to further characterize these cells and identify the main factors responsible for promoting stemness. Osteoprotegerin (OPG) is one of these factors, which could potentiate stemness features in breast cancer cells. OPG is a secreted glycoprotein belonging to the tumor necrosis factor receptor (TNFR) superfamily. OPG was ﬁrst identiﬁed and named for its function in bone remodeling and homeostasis [6] . In this context, OPG is acting as a decoy receptor for another TNF superfamily member Receptor Activator of NF-κB Ligand (RANKL; TNFSF11), and blocks its interaction with RANK (TNFRSF11A), and thereby prevents the stimulation of osteoclast maturation and bone resorption [6, 7] . In contrast, subsequent investigations indicated  \nthat OPG also acts as a decoy receptor by binding to another TNF superfamily member, TNF-Related Apoptosis Inducing Ligand (TRAIL; TNFSF10), and thus prevents TRAIL-induced apoptosis in cell-expressing OPG [8] . Thereby, OPG may also have a protective anti-apoptotic effect, and ac","cbCaisRymFo8MxkX","https://ap.wps.com/l/cbCaisRymFo8MxkX","pdf",4046866,12,"English","# Background\n# Results\n## OPG upregulation promotes breast carcinogenesis and downregulates ERα","[{\"question\":\"What is the main focus of this study on osteoprotegerin (OPG)?\",\"answer\":\"The study examines how endogenous OPG influences breast cancer progression by repressing ERα and promoting stemness-related behaviors and chemoresistance in breast cancer cells.\"},{\"question\":\"How does OPG affect stemness and EMT in breast cancer cells?\",\"answer\":\"Ectopic OPG expression promotes pro-metastatic processes including epithelial-to-mesenchymal transition (EMT) and stemness, while OPG upregulation correlates with proteins involved in these pathways.\"},{\"question\":\"Does OPG change sensitivity to chemotherapy drugs?\",\"answer\":\"Yes. OPG upregulation enhances resistance of luminal breast cancer cells to cisplatin and docetaxel, whereas OPG downregulation sensitizes triple-negative breast cancer cells to these drugs.\"}]","Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells | PDF",1790016051,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34ddef55ddebfc28437756735938b9f7.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c7ae5778e61f176bdba13deb1ab342f.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5cf13c7078e96645ea84282ece38946.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74ddf2b44118593e6692c38ed49919fe.webp",980,1301]